首页> 外文期刊>Chemical Physics: A Journal Devoted to Experimental and Theoretical Research Involving Problems of Both a Chemical and Physical Nature >Synthesis, spectroscopic characterization and molecular docking study of ethyl 2-(4-(5, 9-dihydro-6-hydroxy-2-mercapto-4H-purin-8-ylthio) thiophen-2-yl)-2-oxoacetate molecule for the chemotherapeutic treatment of breast cancer cells
【24h】

Synthesis, spectroscopic characterization and molecular docking study of ethyl 2-(4-(5, 9-dihydro-6-hydroxy-2-mercapto-4H-purin-8-ylthio) thiophen-2-yl)-2-oxoacetate molecule for the chemotherapeutic treatment of breast cancer cells

机译:乙基2-(4-(5,0-二氢-6-羟基-2-巯基-8-巯基-8-基-8-硫硫硫基-8-硫酮-8-基-8-硫酮)-2-氧乙酸酯分子的合成,光谱表征及分子对接研究 乳腺癌细胞的化学治疗

获取原文
获取原文并翻译 | 示例
           

摘要

We designed, prepared and evaluated a new ligand Ethyl 2-(4-(5, 9-dihydro-6-hydroxy-2-mercapto-4H-purin-8-ylthio) thiophen-2-yl)-2-oxoacetate for anticancer activity against a panel of the human breast cancer cell. The FT-IR and FT-Raman spectroscopies represent one of the most powerful techniques to study chemical bonding and chemistry identify molecular structure. The results of a study on the Geometries, Electrostatic potential energy map and electronic properties of 6HPET were investigated by ab initio and Density Functional Theory (DFT) with B3LYP functional. The Protein-Ligand (6HPET) interaction plays a significant role in structural properties of the designed drug molecule. Molecular docking results were performed by using the FlexX and LeadIT docking software and the binding energies were obtained as scores from -31.976, -30.8060 and -29.2660 kcal/mol. The above-mentioned compounds can be utilized to the breast cancer therapy and it leads a way to create platforms for chemotherapy or hormonal therapy of breast cancer treatments.
机译:我们设计,制备和评估了新的配体乙基2-(4-(5,9-二氢-6-羟基-2-巯基-4H-五硫蛋白-8-巯基-8-硫酮-8-硫酮-8-硫酮-8-硫酮)-2-氧代乙酸盐,用于抗癌针对人乳腺癌细胞面板的活性。 FT-IR和Ft-拉曼光谱代表了研究化学键合和化学识别分子结构的最强大的技术之一。用B3LYP功能研究了对几何的研究,静电势能图和6Hpet的电子性质,静电函数理论(DFT)进行了研究。蛋白质 - 配体(6HPET)相互作用在设计的药物分子的结构性质中起着重要作用。通过使用Flexx和引线对接软件进行分子对接结果,并获得与-31.976,-30.8060和-29.2660 kcal / mol的结合能量。上述化合物可用于乳腺癌治疗,并导致一种为乳腺癌治疗的化疗或荷尔蒙治疗创造平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号